Trogarzo
| Chemical Name | ibalizumab-uiyk |
| Dosage Form | Injectable (intravenous; 150 mg/mL) |
| Drug Class | Monoclonal antibodies |
| System | Blood |
| Company | Taimed Biologics USA |
| Approval Year | 2018 |
Indication
- Trogarzo in combination with other antiretroviral(s), is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen.